Lobaplatin
Sponsors
Harbin Medical University, Guiyang Medical University, Fifth Affiliated Hospital, Sun Yat-Sen University, Sun Yat-sen University, Henan Cancer Hospital
Conditions
Acute Toxic EffectsBreast CancerChemotherapyChemotherapy EffectColorectal CancerEsophageal CancerGastric CancerHead and Neck Squamous Cell Carcinoma
Phase 1
Phase 2
Effectiveness and Toxicity of Gemcitabine/Lobaplatin Versus Gemcitabine/Cisplatin as Second-line Treatment in Metastatic Breast Cancer
NCT01483300
Start: 2011-11-30End: 2014-11-30Target: 80Updated: 2012-01-24
Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced SCCHN
NCT03117257
Start: 2016-08-19End: 2021-08-20Target: 144Updated: 2017-04-17
A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC.
NCT03210389
Start: 2017-07-31End: 2021-12-31Target: 60Updated: 2017-07-06
A Study of Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLC
NCT03700359
Start: 2019-03-01End: 2021-11-29Target: 60Updated: 2019-11-29
Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy
NCT04808466
Start: 2021-09-18End: 2025-09-01Target: 231Updated: 2022-02-21
Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy
Not yet recruitingNCT04845490
Start: 2022-09-01End: 2026-09-01Target: 201Updated: 2022-02-21
Eribulin Mesylate Combined With Lobaplatin in the Treatment of Recurrent or Metastatic Triple-negative Breast Cancer
NCT05546255
Start: 2020-06-01End: 2023-12-31Target: 40Updated: 2022-09-19
Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma
NCT06170697
Start: 2023-03-01End: 2025-07-31Target: 46Updated: 2023-12-20
Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma
RecruitingNCT06714383
Start: 2024-11-13End: 2025-11-30Target: 50Updated: 2024-12-03
Phase 3
Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial
RecruitingNCT05701436
Start: 2022-09-01End: 2026-03-01Target: 144Updated: 2023-03-02
Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial
RecruitingNCT05766605
Start: 2023-01-01End: 2026-01-30Target: 90Updated: 2023-03-13
A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC
Not yet recruitingNCT05780294
Start: 2023-04-01End: 2029-12-01Target: 132Updated: 2023-03-22
Phase 4
Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma
CompletedNCT03413436
Start: 2018-01-31End: 2018-02-21Updated: 2020-08-28
Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer
Not yet recruitingNCT07093931
Start: 2025-08-01End: 2030-08-01Target: 468Updated: 2025-07-30